Parkman Healthcare Partners’s McKesson MCK Stock Holding History
Bought
Maintained
Sold
Other funds holding MCK
VCM
VPM
Parkman Healthcare Partners's MCK Position: Q1 2026 in Review
Parkman Healthcare Partners reduced its McKesson (MCK) stake by 65% in Q1 2026, selling an estimated $21.1M and leaving 12,676 shares worth $11M. The position accounts for 1.13% of the portfolio, ranked #29.
Parkman Healthcare Partners first reported a position in MCK in Q4 2024 and has held it in 6 quarters since. The position peaked at $29.8M in Q4 2025. 2,034 funds tracked by Wall St. Rank hold MCK as of Q1 2026.
- Parkman Healthcare Partners held 12,676 shares of McKesson worth $11M as of Q1 2026.
- Parkman Healthcare Partners sold 23,679 McKesson shares in Q1 2026, an estimated $21.1M.
- McKesson made up 1.13% of Parkman Healthcare Partners's portfolio in Q1 2026, its #29 holding.
- Parkman Healthcare Partners first reported a position in McKesson in Q4 2024 and has held it in 6 quarters since.
- Parkman Healthcare Partners's McKesson position peaked at $29.8M in Q4 2025.
- 2,034 funds tracked by Wall St. Rank held McKesson as of Q1 2026.
Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.